SoftBank, the Japanese tech conglomerate famous for paying questionable sums to invest in startups, has paid a hefty sum to invest in the genome sequencing company Pacific Biosciences.
It’s a $900 million investment in the form of convertible debt, meaning SoftBank can exchange the money for stock at a price of $43.50 per share.
About the Author Reprints
